Pangaea Oncology, S.A. Share Price BME
Equities
ES0105221008
Biotechnology & Medical Research
Sales 2024 * | 13.8M 14.99M 1.18B | Sales 2025 * | 14.8M 16.08M 1.27B | Capitalization | 54.18M 58.87M 4.65B |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.09M -85.82M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 4.32 x |
Net Debt 2024 * | 5.5M 5.98M 472M | Net Debt 2025 * | 6.8M 7.39M 584M | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
-36.8
x | P/E ratio 2025 * |
-92
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.08% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.13% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |